These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 8389178)
41. Role of adjuvant treatment in liver transplantation for advanced hepatocellular carcinoma. Cherqui D J Hepatobiliary Pancreat Surg; 1998; 5(1):35-40. PubMed ID: 9683752 [TBL] [Abstract][Full Text] [Related]
42. [Indication and results of liver transplantation]. Pichlmayr R; Brölsch C; Neuhaus P; Wonigeit K Z Gastroenterol Verh; 1983 Apr; 18():70-4. PubMed ID: 6192611 [No Abstract] [Full Text] [Related]
43. Ligation of a branch of the portal vein for carcinoma of the liver. Honjo I; Suzuki T; Ozawa K; Takasan H; Kitamura O Am J Surg; 1975 Sep; 130(3):296-302. PubMed ID: 170837 [TBL] [Abstract][Full Text] [Related]
44. Sorafenib use in the transplant setting. Castelli G; Burra P; Giacomin A; Vitale A; Senzolo M; Cillo U; Farinati F Liver Transpl; 2014 Sep; 20(9):1021-8. PubMed ID: 24809799 [TBL] [Abstract][Full Text] [Related]
45. [Results of the surgical treatment of malignant liver tumors]. Zhuravlev VA; Korepanov VI; Vasil'ev PN Vopr Onkol; 1972; 18(10):36-42. PubMed ID: 4351070 [No Abstract] [Full Text] [Related]
46. A prospective, randomized, multi-centre trial of systemic adjuvant chemotherapy versus no additional treatment in liver transplantation for hepatocellular carcinoma. Söderdahl G; Bäckman L; Isoniemi H; Cahlin C; Höckerstedt K; Broomé U; Mäkisalo H; Friman S; Ericzon BG Transpl Int; 2006 Apr; 19(4):288-94. PubMed ID: 16573544 [TBL] [Abstract][Full Text] [Related]
53. Hepatocellular carcinoma: the search for innovative adjuvant therapies. Yen Y; Zhou W Oncology (Williston Park); 2009 Dec; 23(14):1291, 1294. PubMed ID: 20120843 [No Abstract] [Full Text] [Related]
54. Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy. Saab S; McTigue M; Finn RS; Busuttil RW Exp Clin Transplant; 2010 Dec; 8(4):307-13. PubMed ID: 21143097 [TBL] [Abstract][Full Text] [Related]
55. Liver transplantation for hepatocellular carcinoma: who benefits and who is harmed? Volk M; Marrero JA Gastroenterology; 2008 May; 134(5):1612-4. PubMed ID: 18471530 [No Abstract] [Full Text] [Related]
56. Getting a handle on posttransplant recurrence of HCC. de Vera ME Oncology (Williston Park); 2009 Dec; 23(14):1287, 1291. PubMed ID: 20120842 [No Abstract] [Full Text] [Related]
58. Subrenal capsule assay using liver cancer specimens obtained by fine needle biopsy. Fukushima H Kurume Med J; 1991; 38(3):181-6. PubMed ID: 1664008 [TBL] [Abstract][Full Text] [Related]
59. Clinico-pathological features and surgical management of primary epithelial hepatic malignancies. Heuschen UA; Hofmann WJ; Otto HF; Schlag P; Herfarth C Eur J Surg Oncol; 1990 Aug; 16(4):332-45. PubMed ID: 1696213 [TBL] [Abstract][Full Text] [Related]
60. Liver transplantation for hepatocellular carcinoma - factors influencing outcome and disease-free survival. Fahrner R; Dondorf F; Ardelt M; Dittmar Y; Settmacher U; Rauchfuß F World J Gastroenterol; 2015 Nov; 21(42):12071-82. PubMed ID: 26576092 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]